Annalisa graduated in Medical Biotechnology (bachelor degree, 110/110) at the University of Milan (Italy) in July 2012. In July 2014 she got a master degree in in Neurobiology ( 100/100 cum laude) at the University of Pavia (Italy) with a thesis on the role of the synapse protein SNAP-25 in neurological disorders, under the supervision of Professor Michela Matteoli (Humanitas Institute). After one year of fellowship, she started her PhD program in Neuroscience under the supervision of Dr. Laura Cancedda and Dr. Marco De Vivo at IIT. During these 3 years she focused on the discovery and characterization of a novel drug candidate, which resulted in ameliorating core symptoms in Down syndrome and autism models. She obtained her PhD in Neuroscience in February 2019.
She currently holds a position of Post Doc at Fondazione Telethon, affiliated to the Brain Development & Disease lab at IIT. During these years Annalisa has planned and performed further preclinical analysis for the development of the drug candidate toward advanced preclinical phases.
Annalisa expertise include in vivo transfection of nucleic acids (in utero electroporation),in vitro and in vivo pharmacology, biochemistry and cell/molecular biology, rodent behavioral testing. In addition to her technical expertise, she has writing and editing experience.